vasodilators

网络  血管扩张剂; 血管扩张药; 扩血管药; 血管舒张药; 血管舒张剂



双语例句

  1. As a result, according to the poster," Caution should be exercised when using pulmonary vasodilators such as iloprost in patients with fixed lung disease. "
    据后期结果“当运用肺部血管扩张剂如应伊洛前列素在复杂肺部疾病患者中应警惕。”
  2. Methods Administration of sufficient dose of corticosteroids, vasodilators, vitamins and neurotrophic drugs in38 cases of traumatic optic neuropathy in the early stage and its effect were observed.
    方法将38例(38眼)外伤性视神经损伤早期应用大剂量皮质类固醇、脱水剂、血管扩张剂、维生素及神经营养药物治疗结果进行分析。
  3. Treatment with CPAP did not affect baseline forearm blood flow, the investigators say, but treatment with CPAP for6 weeks improved forearm blood flow response to all vasodilators.
    CPAP治疗并不影响前臂血流的基础流量,研究者说,但经过持续6周的CPAP治疗后其对所有血管舒张剂的反应性增加。
  4. Vasodilators may step up the heart rate and cause headaches.
    血管扩张会加速心跳并引起头痛。
  5. While the decision to use vasodilators or inotropes was determined by hemodynamic parameters and renal function, the main factor was treatment site, the authors note in the American Heart Journal.
    虽然应用血管扩张剂和收缩剂取决于血液动力学参数和肾功能,主要的因素是治疗单位,作者在美国心脏杂志中注释这种情况。
  6. In the absence of hypotension, vasodilators are recommended for most patients with AHF as first line therapy.
    AHF不伴低血压患者的一线治疗药物为血管扩张剂。
  7. Conclusion Sufficient dose of corticosteroids and vasodilators were effective for traumatic optic neuropathy.
    结论大剂量皮质类固醇和血管扩张剂等治疗外伤性视神经损伤有明显效果。
  8. Pharmacologic treatment of postoperative hypertension includes usage of vasodilators, adrenergic inhibitors, and calcium channel blockers.
    术后高血压的药物治疗包括使用血管扩张剂、肾上腺素抑制剂和钙通道阻滞剂。
  9. Usage: Applies to digitalis, diuretics, vasodilators invalid or ineffective treatment of the various causes of acute and chronic refractory congestive heart failure.
    用途:适用于对洋地黄、利尿剂、血管扩张剂治疗无效或效果欠佳的各种原因引起的急、慢性顽固性充血性心力衰竭。
  10. A disadvantage of all vasodilators is their potential to cause a reflex tachycardia.
    所有血管扩张剂都有可能引起反射性心动过速的缺点。
  11. Objective To observe the characteristics of vasoconstriction caused by endothelin-1 and determine the antagonistic effect of vasodilators.
    目的研究内皮素1(Endothelin1,ET1)收缩血管的特性及显微血管外科常用舒张药物的对抗效应。
  12. Contractile effect of endothelin-1 on isolated artery and the antagonistic effect of vasodilators
    内皮素-1对离体动脉的收缩作用及舒张药物的对抗效应
  13. Effect of Vasodilators on Pulmonary Hypertension of Neonates
    扩血管药物对新生儿肺动脉高压治疗效果与方法探讨
  14. Objective It has been known that hepatopulmonary syndrome ( HPS) is related to the imbalance between vasoconstrictors and vasodilators.
    目的肝肺综合征(HPS)的发生与血循环或肺内扩张/收缩血管物质失衡密切相关。
  15. Eight trials reported the side effects of vasodilators, such as pruritus, allergy, etc.
    8个试验描述了瘙痒、过敏等副作用。
  16. Conclusions The experiment provided reference data for the research of vasodilators.
    结论本工作为血管扩张药的研究提供了参考依据。
  17. The conventional treatments for acute heart failure, such as diuretics, vasodilators, catecholamines, phosphodiesterase inhibitors, are not only single action treatments, but also limited.
    治疗急性心力衰竭的传统药物,如:利尿剂、血管扩张剂、肾上腺素能受体激动剂、磷酸二酯酶抑制剂等不仅作用单一,而且各有其局限性。
  18. Conclusion Both NTG and SNP nebulization could be used as selective pulmonary vasodilators for acute hypoxic pulmonary hypertension.
    结论雾化吸入NTG或SNP能选择性地降低急性低氧引起的肺动脉高压。
  19. The contrast group was 40 cases ( 40 eyes) which were treated only by using vasodilators and vitamines.
    并以40例(49眼)仅用血管扩张剂和维生素治疗作为对照组。
  20. Comparative Effects of Common Vasodilators on Experimental Cardiac Failure
    常用血管扩张剂对实验性心力衰竭的作用比较
  21. RESEARCH ON THE GEO AGENTS Study on vasodilation of vasodilators
    Geo-Agents研究血管舒张药物解痉作用的研究
  22. Exclusion criteria: cardiogenic shock, hypovolemia, or any other clinical conditions given vasodilators are contraindicated; serious liver and kidney dysfunction; significant valvular stenosis; hypertrophic, restrictive cardiomyopathy; constrictive pericarditis.
    排除标准:心源性休克、血容量不足或任何其他临床情况禁忌给予血管扩张剂者;严重肝肾功能不全者;明显瓣膜狭窄者;肥厚型、限制型心肌病;缩窄性心包炎。
  23. At present, the treatments of vasodilators on severe pulmonary hypertension have not been satisfactory and brought about many side effects.
    目前,对各类重症肺动脉高压患者的药物治疗效果多不满意,且有较多副作用。